PUBLISHER: IMARC | PRODUCT CODE: 2024584
PUBLISHER: IMARC | PRODUCT CODE: 2024584
Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2026-2034
The global women's health diagnostics market size reached USD 33.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 56.1 Billion by 2034, exhibiting a growth rate (CAGR) of 5.86% during 2026-2034. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women's health through numerous campaigns and initiatives by the governments and public organizations, increasing acceptance rate of point-of-care diagnostics, and rapid growth in telemedicine and remote diagnostics industry.
WOMEN'S HEALTH DIAGNOSTICS MARKET ANALYSIS :
- Major Market Drivers: Some of the major market drivers include the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments, and rising awareness and emphasis on the health of women.
- Key Market Trends: Rapid growth of the telemedicine and remote diagnostics market, increasing adoption of point-of-care diagnostics, and increasing number of research and development (R&D) activities are some key market trends of the industry.
- Geographical Trends: North America dominates the women's health diagnostics industry due to its robust health infrastructure and cutting-edge competition within the industry. Europe holds second position on account of the rising number of individuals diagnosed with chronic diseases and increasing awareness about women's health.
- Competitive Landscape: Abbott Laboratories, Aspira Women's Health, Becton Dickinson and Company, bioMerieux, Cepheid (Danaher Corporation), F. Hoffmann-La Roche Ltd, GE HealthCare, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics, Siemens Healthineers AG and Thermo Fisher Scientific Inc., are among some of the key players in the women's health diagnostics industry.
- Challenges and Opportunities: Women's health diagnostics market recent opportunities include positioning in untapped markets and significant developments in personalized genomics and medicine. Whereas, challenges include expensive diagnostic tests and equipment and restricted access to healthcare facilities in rural regions.
WOMEN'S HEALTH DIAGNOSTICS MARKET TRENDS :
Substantial Rise in the Number of Females Diagnosed with Chronic and Lifestyle-Related Disorders
One of the primary factors driving the market is the increasing prevalence of chronic and lifestyle-related diseases amongst women. These include, cervical cancer, osteoporosis, cardiovascular diseases, and breast cancer. According to the WORLD HEALTH ORGANIZATION (WHO), breast cancer is one of the leading causes of death among women globally. Approximately 2.3 million women were diagnosed with breast cancer and 6,70,000 succumbed to it globally, in the year 2022. The report also states that in nations with an exceptionally high Human Development Index (HDI), the chances of occurrence of breast cancer is relatively high as compared to nations with a lower HDI. This increasing prevalence of these diseases is leading to a higher women's health diagnostics demand globally. One of the leading causes of these diseases is the sedentary lifestyles and poor dietary habits, which also lead to illnesses such as obesity and diabetes. Chronic illnesses usually require constant monitoring and management, thereby propelling the market growth. Other than this, the rising awareness about the importance of early detection is also playing a vital role.
Rising Government Initiatives
The rising government initiatives in order to spread awareness about the chronic illnesses prevalent amongst women, is creating a positive women's health diagnostics market overview. The increased awareness and education associated with the distinctive health challenges faced by women in confluence with the importance of regular health screenings is driving the market. In order to achieve this, governments, non-profit, and public organizations organize campaigns focusing on the importance of early detection and preventive care. One of the most renowned campaigns for breast cancer is the BREAST CANCER AWARENESS MONTH, which runs through the entire month of October. This initiative was started in the year 1985 through a productive collaboration between the AMERICAN CANCER SOCIETY and IMPERIAL CHEMICAL INDUSTRIES, which is ever since a part of ASTRAZENECA, a major producer of breast cancer medications. The campaign increases awareness around the disease and also raises funds for its treatments, and research. The awareness month includes numerous social media campaigns, walking events, and races taking place across the globe.
Rising Acceptance of Point-of-Care Diagnostics
The increasing acceptance of point-of-care diagnostics is further driving the women's health diagnostics market growth. The rising adoption of this type of diagnostics can be attributed to the advantage of conducing diagnostic tests nearby the patient, thereby offering immediate results and allowing faster clinical decision-making. This technique is majorly useful in cases where timely diagnosis can significantly impact treatment directions, such as in pregnancy-related complexities, cancer screenings, and sexually transmitted infections. According to a report published by the IMARC GROUP, the global point-of-care diagnostics market reached US$ 49.2 Billion in 2023, and is projected to reach US$ 99.5 Billion by 2032, reflecting a CAGR of 7.9% during 2024-2032. The report further mentioned numerous key players entering in partnerships in order to offer distinctive and dependable diagnostic solutions in order to transform the healthcare delivery. For instance, MOLBIO DIAGNOSTICS announced its collaboration with SIGTUPLE in the year 2023, for the development of next-generation AI-enabled movable devices for numerous routine and diagnostic tests.
WOMEN'S HEALTH DIAGNOSTICS INDUSTRY SEGMENTATION:
Breakup by Type:
- Diagnostic Devices
- Biopsy Device
- Imaging and Monitoring Devices
- Accessories and Consumables
- Diagnostic Tests
- Breast Cancer Testing
- PAP Smear and HPV Test
- Pregnancy Testing and Ovulation Testing
- Others
Diagnostic Devices accounts for the majority of the market share
According to the women's health diagnostics forecast, diagnostic services dominate the market on account of the wide array of vital tests and screening possessed by them, which are important for early detection and management of numerous health conditions. Some of the most commonly available services include ultrasound, PAP smear tests, mammography, and blood tests which assist in the routine monitoring of specific conditions related to women's health. Other than this, the rising number of females suffering with chronic illnesses is leading to a rise in the demand for regular health check up drives, thereby creating a positive women's health diagnostics outlook. Moreover, the diagnostic services maintain a leading position within the industry also on account of the rising prevalence of the home diagnostic services. As per a market research report published by GITNUX, the global home diagnostics market is projected to reach USD 6.53 Billion by 201-2025.
Breakup by Application:
- Breast Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Sexually Transmitted Disease Testing
Infectious disease testing holds the largest share in the industry
Infectious disease testing dominates the market growth on account of the rising number of sexually-transmitted infections (STIs) and numerous other communicable diseases. According to the WORLD HEALTH ORGANIZATION (WHO), more than 1 million individuals are diagnosed with sexually transmitted diseases (ATIs) every single day, globally. Majority of these diagnosed cases are asymptomatic. In order to seamlessly and effectively manage these conditions, there is a crucial requirement for appropriate management and treatment solutions. Other than this, the rising awareness amongst individuals regarding these conditions is also driving the infectious disease testing market. According to GITNUX, the infectious disease testing market is exhibiting a CAGR of 7% during 2021-2026. Moreover, governments and public organizations across the globe are taking initiatives to promote regular testing for these diseases.
Breakup by End User:
- Hospital and Diagnostics Centers
- Home Care
Hospital and diagnostics centers represent the leading market segment
Hospital and diagnostic centers represent the largest segment on account of their holistic healthcare services, developed diagnostic technologies, and capability to handle a high volume of patients. These services provide customized expertise and infrastructure for precise and early detection of complicated health conditions which seek effective treatment planning beforehand. Other than this, the rising number of hospitals globally is also a significant factor driving the market. According to the AMERICAN HOSPITAL ASSOCITION, there are 6,120 hospitals in the United States. These centers are usually the first point of care for numerous females seeking medical aid, which further contributes positively to the women's health diagnostic market revenue.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America leads the market, accounting for the largest women's health diagnostics market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America dominates the market on account of its robust healthcare infrastructure, presence of prominent key players and a significant rise in the healthcare expenditure across the United States. According to the AMERICAN MEDICAL ASSOCIATION (AMA), the health spending in the United States increased by 4.1% in 2022 to $4.4 Trillion or $13,493 per capita. The region particularly places a significant emphasis on early diagnosis and preventive care, in confluence with significant investment in research and development (R&D) activities thereby driving the market growth. Other factors driving the market include rising awareness campaigns, favorable reimbursement policies which further support the adoption of women's health diagnostics recent developments.
COMPETITIVE LANDSCAPE:
Major women's health diagnostics companies are significantly focusing on innovation and improving their product portfolios in order to improve diagnostic accuracy and efficiency. Additionally, they are also investing substantially in research and development (R&D) activities in order to launch advanced technologies including molecular diagnostics, AI-driven diagnostic tools, and next-generation sequencing. Prominent key players are also entering into strategic collaborations and acquisitions in order to enter untapped markets. For instance, in April 2023 QUEST DIAGNOSTICS and NEW YORK-PRESBYTERIAN announced that the former completes its acquisition fo selected assets of the laboratory services business of NEWYORK- PRESBYTERIAN. This strategic collaboration in meant to enable providers and patients to access good-quality, economical testing from a service menu that integrates the complementary strengths of both organizations.
The report provides a comprehensive analysis of the competitive landscape in the global women's health diagnostics market with detailed profiles of all major companies, including:
- Abbott Laboratories
- Aspira Women's Health
- Becton Dickinson and Company
- bioMerieux
- Cepheid (Danaher Corporation)
- F. Hoffmann-La Roche Ltd
- GE HealthCare
- Hologic, Inc.
- Koninklijke Philips N.V.
- Quest Diagnostics
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Women's Health Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Diagnostic Devices
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Biopsy Device
- 6.1.2.2 Imaging and Monitoring Devices
- 6.1.2.3 Accessories and Consumables
- 6.1.3 Market Forecast
- 6.2 Diagnostic Tests
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Breast Cancer Testing
- 6.2.2.2 PAP Smear and HPV Test
- 6.2.2.3 Pregnancy Testing and Ovulation Testing
- 6.2.2.4 Others
- 6.2.3 Market Forecast
7 Market Breakup by Application
- 7.1 Breast Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Infectious Disease Testing
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Osteoporosis Testing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Pregnancy and Fertility Testing
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Sexually Transmitted Disease Testing
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospital and Diagnostics Centers
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Home Care
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Aspira Women's Health
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Becton Dickinson and Company
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 bioMerieux
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Cepheid (Danaher Corporation)
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 F. Hoffmann-La Roche Ltd
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 GE HealthCare
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Hologic, Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Koninklijke Philips N.V.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Quest Diagnostics
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Siemens Healthineers AG
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Thermo Fisher Scientific Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.1 Abbott Laboratories
List of Figures
- Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion USD), 2020-2025
- Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
- Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2025
- Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2025
- Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2025
- Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2025
- Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2025
- Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
- Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
- Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2025 and 2034
- Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million USD), 2026-2034
- Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million USD), 2026-2034
- Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
- Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
- Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
- Table 7: Global: Women's Health Diagnostics Market: Key Players
